Co-Diagnostics, Inc. financial data

Symbol
CODX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
4049 South Highland Drive, Salt Lake City, UT
State of incorporation
Utah
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.1K % -42.9%
Quick Ratio 42.9 % -61.5%
Debt-to-equity 10.4 % +30.2%
Return On Equity -44.7 % -36.5%
Return On Assets -40.5 % -33.5%
Operating Margin -424 % +43.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.9M shares +3.65%
Common Stock, Shares, Outstanding 31.9M shares +3.65%
Entity Public Float 33M USD -82.4%
Common Stock, Value, Issued 36.8K USD +4%
Weighted Average Number of Shares Outstanding, Basic 30.1M shares +3.56%
Weighted Average Number of Shares Outstanding, Diluted 30.1M shares +3.56%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.14M USD +25.2%
Cost of Revenue 3.67M USD +63.5%
Research and Development Expense 23.3M USD +12%
Selling and Marketing Expense 6.03M USD -9.51%
General and Administrative Expense 13.6M USD -12.8%
Operating Income (Loss) -38.7M USD +29.1%
Nonoperating Income (Expense) 2.89M USD -58.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -35.8M USD +24.9%
Income Tax Expense (Benefit) 1.76M USD
Net Income (Loss) Attributable to Parent -37.6M USD +0.98%
Earnings Per Share, Basic -1.25 USD/shares -1.63%
Earnings Per Share, Diluted -1.25 USD/shares -2.46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.9M USD +0.2%
Marketable Securities, Current 31M USD -43.9%
Accounts Receivable, after Allowance for Credit Loss, Current 552K USD -49.7%
Inventory, Net 1.46M USD -68.8%
Assets, Current 48.2M USD -37.7%
Deferred Income Tax Assets, Net 4.27M USD
Property, Plant and Equipment, Net 3.05M USD +9.28%
Operating Lease, Right-of-Use Asset 2.55M USD -21.1%
Intangible Assets, Net (Excluding Goodwill) 26.3M USD -1.14%
Goodwill 15.4M USD
Assets 80.7M USD -28.5%
Accounts Payable, Current 1.86M USD +8.84%
Accrued Liabilities, Current 1.5M USD -7.61%
Contract with Customer, Liability, Current 221K USD -14.4%
Liabilities, Current 5.31M USD +3.71%
Deferred Income Tax Liabilities, Net 203K USD -96.5%
Operating Lease, Liability, Noncurrent 1.7M USD -30.7%
Liabilities 8.3M USD -11.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 371K USD -35.9%
Retained Earnings (Accumulated Deficit) -12.3M USD -149%
Stockholders' Equity Attributable to Parent 72.4M USD -30%
Liabilities and Equity 80.7M USD -28.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.49M USD -43.5%
Net Cash Provided by (Used in) Financing Activities -482K USD -421%
Net Cash Provided by (Used in) Investing Activities 16.7M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 36.8M shares +3.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.18M USD
Deferred Tax Assets, Valuation Allowance 6.94M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 15.3M USD +197%
Operating Lease, Liability 2.58M USD -20.1%
Payments to Acquire Property, Plant, and Equipment 402K USD +124%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -37.8M USD -1.11%
Lessee, Operating Lease, Liability, to be Paid 2.84M USD -22%
Operating Lease, Liability, Current 878K USD +13.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 715K USD -26.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD +118%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -2.21M USD -62.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 262K USD -36.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 301K USD -69.6%
Deferred Tax Assets, Operating Loss Carryforwards 4.04M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.08M USD -26.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 308K USD -54.8%
Operating Lease, Payments 262K USD +38.9%
Additional Paid in Capital 99.9M USD +7.62%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 50.8K USD
Depreciation, Depletion and Amortization 331K USD +4.61%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 303K USD
Deferred Tax Assets, Net of Valuation Allowance 8.33M USD +61.9%
Share-based Payment Arrangement, Expense 7.07M USD -21.2%
Operating Leases, Future Minimum Payments Due 647K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%